| Synonyms: | |
| Status: | Approved |
| Entry Type: | Gene |
| Molecule Category: | UNKNOWN |
| ATC: | L01XX51 |
| UNII: | 07730V90L6 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| DISRUPTING AGENT | Melanoma cell disrupting agent |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Melanoma | 4 | D008545 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Sarcoma, Kaposi | 2 | D012514 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Carcinoma, Intraductal, Noninfiltrating | 1 | D002285 | ClinicalTrials |
| Head and Neck Neoplasms | 1 | D006258 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Glioma | 1 | D005910 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108727 |
| FDA SRS | 07730V90L6 |
CONTENTS